FIELD: medicine; pharmacology; experimental gastroenterology.
SUBSTANCE: experimental animal that has undergone modeling of ulcerative colitis is parenterally administered Dalargin dissolved in physiological sodium chloride solution at a dose of 100.0 mcg per 1 kg of body weight. The drug is administered seven times with an interval of 24 hours between injections, starting from the first day of ulcerative colitis modeling.
EFFECT: method makes it possible to prevent the development of complications of ulcerative colitis that threaten the patient's life, as well as to improve the quality of life of patients suffering from ulcerative colitis.
1 cl, 5 dwg, 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING ULCERATIVE COLITIS | 2023 |
|
RU2814765C1 |
| METHOD OF MODELING ULCERATIVE DEFECTS OF THE INTESTINAL MUCOSA IN CROHN'S DISEASE ON MINIPIGS | 2022 |
|
RU2798718C1 |
| METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2009 |
|
RU2394571C1 |
| IMMUNOBIOLOGICAL AGENT BASED ON BUTYRATE AND THE METHOD FOR ITS USE FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES | 2021 |
|
RU2780868C1 |
| PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF INTESTINAL MUCOSA INFLAMMATORY DISEASES ON THE BASIS OF LACTOBACILLUS BREVIS 47f STRAIN, MANIFESTING A LOCAL ANTI-INFLAMMATORY ACTIVITY | 2018 |
|
RU2675110C1 |
| METHOD FOR DETERMINING TREATMENT TACTICS IN TREATING CHILDREN FOR NONSPECIFIC ULCERATIVE COLITIS | 2006 |
|
RU2319450C1 |
| PREPARATION FOR TREATMENT OF NONINFECTIOUS INFLAMMATORY INTESTINE DISEASES | 2005 |
|
RU2297835C1 |
| METHOD FOR DETERMINATION OF SEVERITY LEVEL OF ULCERATIVE COLITIS | 2007 |
|
RU2339956C1 |
| METHOD OF TREATING INFLAMMATORY INTESTINAL DISEASES | 2011 |
|
RU2463055C2 |
| METHOD FOR DIAGNOSING DEGREE OF ACTIVITY OF ULCERATIVE COLITIS | 2023 |
|
RU2821756C1 |
